We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera SC
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2012-04453-1-4
Submission Type
New dose form
Decision
Approved